1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Health Economics and Outcomes Research (HEOR) Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Health Economics and Outcomes Research (HEOR) Services Market, by Service,
8.1.1 Economic evaluation
8.1.1.1. Market Revenue and Forecast
8.1.2. Real world data analysis and information
8.1.2.1. Market Revenue and Forecast
8.1.3. Clinical Outcome
8.1.3.1. Market Revenue and Forecast
8.1.4. Market access solution and reimbursement
8.1.4.1. Market Revenue and Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Forecast
9.1. Health Economics and Outcomes Research (HEOR) Services Market, by Service Provider ,
9.1.1. Contract Research Organizations (CROs)
9.1.1.1. Market Revenue and Forecast
9.1.2. Consultancy
9.1.2.1. Market Revenue and Forecast
10.1. Health Economics and Outcomes Research (HEOR) Services Market, by End user,
10.1.1. Government Organizations
10.1.1.1. Market Revenue and Forecast
10.1.2. Healthcare Providers
10.1.2.1. Market Revenue and Forecast
10.1.3. Health Care Payers
10.1.3.1. Market Revenue and Forecast
10.1.4. Pharma and Biotech Companies
10.1.4.1. Market Revenue and Forecast
10.1.5. Others
10.1.5.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service
11.1.2. Market Revenue and Forecast, by Service Provider
11.1.3. Market Revenue and Forecast, by End user
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service
11.1.4.2. Market Revenue and Forecast, by Service Provider
11.1.4.3. Market Revenue and Forecast, by End user
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service
11.1.5.2. Market Revenue and Forecast, by Service Provider
11.1.5.3. Market Revenue and Forecast, by End user
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service
11.2.2. Market Revenue and Forecast, by Service Provider
11.2.3. Market Revenue and Forecast, by End user
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service
11.2.4.2. Market Revenue and Forecast, by Service Provider
11.2.4.3. Market Revenue and Forecast, by End user
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service
11.2.5.2. Market Revenue and Forecast, by Service Provider
11.2.5.3. Market Revenue and Forecast, by End user
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service
11.2.6.2. Market Revenue and Forecast, by Service Provider
11.2.6.3. Market Revenue and Forecast, by End user
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service
11.2.7.2. Market Revenue and Forecast, by Service Provider
11.2.7.3. Market Revenue and Forecast, by End user
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service
11.3.2. Market Revenue and Forecast, by Service Provider
11.3.3. Market Revenue and Forecast, by End user
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service
11.3.4.2. Market Revenue and Forecast, by Service Provider
11.3.4.3. Market Revenue and Forecast, by End user
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service
11.3.5.2. Market Revenue and Forecast, by Service Provider
11.3.5.3. Market Revenue and Forecast, by End user
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service
11.3.6.2. Market Revenue and Forecast, by Service Provider
11.3.6.3. Market Revenue and Forecast, by End user
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service
11.3.7.2. Market Revenue and Forecast, by Service Provider
11.3.7.3. Market Revenue and Forecast, by End user
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service
11.4.2. Market Revenue and Forecast, by Service Provider
11.4.3. Market Revenue and Forecast, by End user
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service
11.4.4.2. Market Revenue and Forecast, by Service Provider
11.4.4.3. Market Revenue and Forecast, by End user
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service
11.4.5.2. Market Revenue and Forecast, by Service Provider
11.4.5.3. Market Revenue and Forecast, by End user
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service
11.4.6.2. Market Revenue and Forecast, by Service Provider
11.4.6.3. Market Revenue and Forecast, by End user
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service
11.4.7.2. Market Revenue and Forecast, by Service Provider
11.4.7.3. Market Revenue and Forecast, by End user
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service
11.5.2. Market Revenue and Forecast, by Service Provider
11.5.3. Market Revenue and Forecast, by End user
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service
11.5.4.2. Market Revenue and Forecast, by Service Provider
11.5.4.3. Market Revenue and Forecast, by End user
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service
11.5.5.2. Market Revenue and Forecast, by Service Provider
11.5.5.3. Market Revenue and Forecast, by End user
12.1. Cardinal Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Axtria
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. McKesson Corp.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. MEDLIOR
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. IQVIA
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. PharmaLex GmbH
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ICON plc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. PPD Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. RTI Health Solutions
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Syneos Health
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
